R

Rapid Micro Biosystems Tech Stack

Automated microbial detection for pharmaceutical manufacturing quality control

Biotechnology Research Lexington, Massachusetts 51–200 employees Founded 2006 Public Company

Rapid Micro Biosystems manufactures the Growth Direct® System, an automation platform that replaces manual microbiology testing in pharmaceutical manufacturing. The company is sales-driven (14 of 30 active hires in sales) and actively scaling go-to-market: current projects span territory planning, sales enablement, onboarding program design, and new-market penetration—all pointing to a scaling sales org working to shorten cycles and increase win rates.

Tech Stack 11 technologies

Core StackAllen-Bradley Siemens Salesforce Word Excel PowerPoint Microsoft Office Ignition Cognex Keyence Outlook

What Rapid Micro Biosystems Is Building

◆Challenges

Service budget management
Increase win rates
Shorten sales cycles
Penetrating new markets
Customer uptime
Validating automated systems
Increasing adoption of growth direct
Expanding key customer footprint globally
Safety and quality improvement
Accelerate ramp time for new hires

▲Active Projects

Validation of automated system
Method qualification support
Multi-site deals
Sales onboarding program design
Penetrate new markets and increase adoption of growth direct
Sales enablement program development
Territory plan to achieve growth targets
Sales content repository creation
Capital equipment sales
Existing account management

Hiring Activity

Accelerating30 roles · 15 in 30d

Department

Sales

14

Support

12

Engineering

1

Manufacturing

1

Marketing

1

Research

1

Seniority

Mid

10

Senior

10

Manager

7

Director

3

Notable leadership hires: Accounts Director

Company intelligence

Find more companies like Rapid Micro Biosystems by tech stack, pain points and active projects

Get started free

About Rapid Micro Biosystems

Rapid Micro Biosystems is a public life sciences company headquartered in Lexington, Massachusetts, with manufacturing operations in Lowell, Massachusetts, and global presence in Switzerland, Germany, and the Netherlands. The Growth Direct® platform automates microbial contamination detection in quality control workflows across pharmaceutical manufacturers, enabling faster release of biologics, vaccines, cell and gene therapies, and sterile injectables. The company sells to large pharma manufacturers worldwide and has evolved from a 2006 startup into a 51–200-person operation serving critical supply-chain functions in the pharmaceutical sector.

HeadquartersLexington, Massachusetts

Company Size51–200 employees

Founded2006

Hiring MarketsUnited States, Ireland, Germany, France, Japan

Frequently Asked Questions

What is Rapid Micro Biosystems' main product?

The Growth Direct® System, an automated platform for microbial contamination detection in pharmaceutical manufacturing quality control. It replaces manual microbiology testing to enable faster, more accurate results.

Where is Rapid Micro Biosystems headquartered?

Lexington, Massachusetts. The company also operates manufacturing facilities in Lowell, Massachusetts, and has global locations in Switzerland, Germany, and the Netherlands.